CLARUS THERAPEUTICS

clarus-therapeutics-logo

Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women. It offers OriTex, a proprietary oral testosterone product for use in men with low testosterone levels.

#SimilarOrganizations #People #Financial #Event #Website #More

CLARUS THERAPEUTICS

Industry:
Biotechnology Health Care Life Science Therapeutics

Founded:
2003-01-01

Address:
Northbrook, Illinois, United States

Country:
United States

Website Url:
http://www.clarustherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
847-562-4300

Email Addresses:
[email protected]

Total Funding:
122 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins


Similar Organizations

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.


Current Advisors List

bruce-robertson_image

Bruce Robertson Board of Directors @ Clarus Therapeutics
Board_member

alex-zisson_image

Alex Zisson Board Membe @ Clarus Therapeutics
Board_member

karen-hong_image

Karen Hong Board of Directors @ Clarus Therapeutics
Board_member

james-e-thomas_image

James E. Thomas Board of Director @ Clarus Therapeutics
Board_member

Current Employees Featured

zhanna-jumadilova_image

Zhanna Jumadilova
Zhanna Jumadilova Chief Clinical Development Officer @ Clarus Therapeutics
Chief Clinical Development Officer
2022-01-17

robert-e-dudley_image

Robert E. Dudley
Robert E. Dudley Founder , Chairman, CEO and President @ Clarus Therapeutics
Founder , Chairman, CEO and President

not_available_image

Steven A. Bourne
Steven A. Bourne CFO @ Clarus Therapeutics
CFO

michael-wasserman_image

Michael Wasserman
Michael Wasserman Bord of Directors @ Clarus Therapeutics
Bord of Directors

Founder


robert-e-dudley_image

Robert E. Dudley

Stock Details


Company's stock symbol is NASDAQ:CRXT

Investors List

hig-capital_image

H.I.G. Capital

H.I.G. Capital investment in Post-IPO Equity - Clarus Therapeutics

c-bridge-capital_image

C-Bridge Capital

C-Bridge Capital investment in Venture Round - Clarus Therapeutics

armentum-partners_image

Armentum Partners

Armentum Partners investment in Debt Financing - Clarus Therapeutics

hig-capital_image

H.I.G. Capital

H.I.G. Capital investment in Series C - Clarus Therapeutics

thomas-mcnerney-partners_image

Thomas, McNerney & Partners

Thomas, McNerney & Partners investment in Series C - Clarus Therapeutics

thomas-mcnerney-partners_image

Thomas, McNerney & Partners

Thomas, McNerney & Partners investment in Series B - Clarus Therapeutics

thomas-mcnerney-partners_image

Thomas, McNerney & Partners

Thomas, McNerney & Partners investment in Series A - Clarus Therapeutics

Official Site Inspections

http://www.clarustherapeutics.com

  • Host name: 104.21.55.80
  • IP address: 104.21.55.80
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Clarus Therapeutics" on Search Engine